More recently, de novo SCN2A mutations have also been identified in patients with intellectual disability (ID), autism spectrum disorder (ASD) or schizophrenia without overt epilepsy, enlarging thus the spectrum of SCN2A-associated disorders7–10. Here, SCN2A is linked to epilepsy.